Accelerant (ARX) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
13 Aug, 2026Executive summary
Announced a definitive agreement to be acquired by Thoma Bravo and transition to a privately held company.
Management team will remain in place, with continued focus on specialty insurance and technology investment.
Communications emphasize stability for employees and members, with ongoing commitment to partners and customers.
Special meeting of shareholders will be convened to approve the merger and related transactions.
Voting matters and shareholder proposals
Shareholders will vote on the approval of the merger agreement and related transactions at a special meeting.
Proxy statement and Schedule 13E-3 will be filed with the SEC, containing details on the merger and participants.
Board of directors and corporate governance
Information on directors, executive officers, and their interests in the merger will be disclosed in the proxy statement.
Any changes in security holdings by directors and officers are reflected in recent SEC filings.
Latest events from Accelerant
- Board and major holders back $20.25/share take-private merger, with strong governance and compliance.ARX
Proxy filing - Definitive agreement for acquisition by Thoma Bravo prompts shareholder vote on merger.ARX
Proxy filing - To be acquired by Thoma Bravo for $20.25/share, going private after strong Q2 growth.ARX
Proxy filing - Exchange Written Premium up 20%, strong earnings, and Thoma Bravo acquisition announced.ARX
Q2 2026 - Accelerant's tech-enabled MGA marketplace drives efficient, resilient growth and strong margins.ARX
46th Annual William Blair Growth Stock Conference - Q1 2026 saw 16% premium growth, 70% higher EBITDA, and strong 2026 guidance.ARX
Q1 2026 - Shareholders will vote on director elections and auditor ratification at the May 2026 meeting.ARX
Proxy filing - FY 2025 saw 35% premium growth, 149% EBITDA increase, and a $200M buyback plan.ARX
Q4 2025 - Exchange Written Premium up 17% and adjusted EBITDA up 302%, offset by IPO-related expense.ARX
Q3 2025